183 related articles for article (PubMed ID: 36413048)
1. Treatment Patterns in Patients with Uterine Fibroids With and Without a Diagnosis of Heavy Menstrual Bleeding: Results from a Large U.S. Claims Database.
McKain L; Edsall K; Dufour R; Lickert C
J Womens Health (Larchmt); 2023 Mar; 32(3):332-340. PubMed ID: 36413048
[No Abstract] [Full Text] [Related]
2. Describing the Patient Journey of Women with Claims for Uterine Fibroids and Heavy Menstrual Bleeding Using a Commercial Database (2011-2020).
Agarwal SK; Stokes M; Kung T; Tilney R; Lickert C
Int J Womens Health; 2023; 15():1561-1575. PubMed ID: 37867928
[TBL] [Abstract][Full Text] [Related]
3. Health Care Costs and Treatment Patterns Associated with Uterine Fibroids and Heavy Menstrual Bleeding: A Claims Analysis.
Wang A; Wang S; Owens CD; Vora JB; Diamond MP
J Womens Health (Larchmt); 2022 Jun; 31(6):856-863. PubMed ID: 34591695
[No Abstract] [Full Text] [Related]
4. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
6. Contemporary treatment utilization among women diagnosed with symptomatic uterine fibroids in the United States.
Bonine NG; Banks E; Harrington A; Vlahiotis A; Moore-Schiltz L; Gillard P
BMC Womens Health; 2020 Aug; 20(1):174. PubMed ID: 32791970
[TBL] [Abstract][Full Text] [Related]
7. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A; Hussain M; Rishworth JR; Rees MC
Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
[TBL] [Abstract][Full Text] [Related]
8. The reporting and diagnosis of uterine fibroids in the UK: an observational study.
Martín-Merino E; Wallander MA; Andersson S; Soriano-Gabarró M; Rodríguez LA
BMC Womens Health; 2016 Jul; 16():45. PubMed ID: 27456692
[TBL] [Abstract][Full Text] [Related]
9. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
Schlaff WD; Ackerman RT; Al-Hendy A; Archer DF; Barnhart KT; Bradley LD; Carr BR; Feinberg EC; Hurtado SM; Kim J; Liu R; Mabey RG; Owens CD; Poindexter A; Puscheck EE; Rodriguez-Ginorio H; Simon JA; Soliman AM; Stewart EA; Watts NB; Muneyyirci-Delale O
N Engl J Med; 2020 Jan; 382(4):328-340. PubMed ID: 31971678
[TBL] [Abstract][Full Text] [Related]
10. Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids.
Lynch SE; Mayer DC
Ann Pharmacother; 2022 Jan; 56(1):93-101. PubMed ID: 33998300
[TBL] [Abstract][Full Text] [Related]
11. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA.
Yao X; Stewart EA; Laughlin-Tommaso SK; Heien HC; Borah BJ
BJOG; 2017 Jan; 124(2):322-330. PubMed ID: 27770484
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Heavy Menstrual Bleeding in Women Not Designated as Responders to Elagolix Plus Add Back Therapy for Uterine Fibroids.
Stewart EA; Archer DF; Owens CD; Barnhart KT; Bradley LD; Feinberg EC; Gillispie-Bell V; Imudia AN; Liu R; Kim JH; Al-Hendy A
J Womens Health (Larchmt); 2022 May; 31(5):698-705. PubMed ID: 34582715
[No Abstract] [Full Text] [Related]
13. Cost burden and treatment patterns associated with management of heavy menstrual bleeding.
Jensen JT; Lefebvre P; Laliberté F; Sarda SP; Law A; Pocoski J; Duh MS
J Womens Health (Larchmt); 2012 May; 21(5):539-47. PubMed ID: 22360696
[TBL] [Abstract][Full Text] [Related]
14. Uterine Fibroids, Perceived Stress, and Menstrual Distress: a Key Role of Heavy Menstrual Bleeding.
Vannuccini S; Clemenza S; Cassioli E; Rossi E; Castellini G; Ricca V; Petraglia F
Reprod Sci; 2023 May; 30(5):1608-1615. PubMed ID: 36471219
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of variation in heavy menstrual bleeding treatments by age and underlying cause.
Copher R; Le Nestour E; Law A; Pocoski J; Zampaglione E
Curr Med Res Opin; 2013 Feb; 29(2):127-39. PubMed ID: 23268728
[TBL] [Abstract][Full Text] [Related]
16. [Summary of the practice guideline 'Heavy menstrual bleeding'].
Vree FE; van der Kooij S; Coppus SF; Janssen CA; Reekers JA; Hehenkamp W
Ned Tijdschr Geneeskd; 2013; 157(48):A6789. PubMed ID: 24279954
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2.
Gemzell-Danielsson K; Heikinheimo O; Zatik J; Poka R; Rechberger T; Hudecek R; Petersdorf K; Ramirez F; Faustmann T; Groettrup-Wolfers E; Seitz C
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():7-14. PubMed ID: 32559602
[TBL] [Abstract][Full Text] [Related]
18. Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up.
Magalhaes J; Ferreira-Filho ES; Soares-Junior JM; Baracat EC
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():56-62. PubMed ID: 35809459
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of the etiology of heavy menstrual bleeding in 2,770 adolescent females.
Hall EM; Ravelo AE; Aronoff SC; Del Vecchio MT
BMC Womens Health; 2024 Feb; 24(1):136. PubMed ID: 38378571
[TBL] [Abstract][Full Text] [Related]
20. Contemporary management of uterine fibroids: focus on emerging medical treatments.
Singh SS; Belland L
Curr Med Res Opin; 2015 Jan; 31(1):1-12. PubMed ID: 25365466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]